Literature DB >> 11016769

Transjugular intrahepatic portosystemic shunt. Experiences at a liver transplantation center.

N Hidajat1, T Vogl, H Stobbe, J Schmidt, C Wex, R Lenzen, T Berg, P Neuhaus, R Felix.   

Abstract

OBJECTIVE: Transjugular intrahepatic portosystemic shunt (TIPS) placement is an established therapy for portal hypertension that leads to variceal bleeding or refractory ascites. We present experiences of the role of TIPS at a liver transplantation center.
MATERIAL AND METHODS: One hundred and ten patients were referred to the Radiological Department for TIPS placement. One of the 110 patients had recurrent cirrhosis after liver transplantation with refractory ascites. Function of the TIPS was controlled with Doppler US at 1 day, 1 week, 4 weeks and 4 months after TIPS placement and subsequently every 3 months. Shunt insufficiency was supposed when the blood flow velocity within the stent tract was under 50 cm/s and was an indication for TIPS revision.
RESULTS: TIPS was placed in 101 patients. After TIPS placement, 10 patients underwent liver transplantation. While waiting for the new liver, none of them developed variceal rebleeding, ascites or other complications of portal hypertension. Two of the 101 patients had episodes of rebleeding. The frequency of patients undergoing TIPS revision within the first year after TIPS placement was 67.5%, within the second year 38.0% and within the third year 24.4%. The revisions led to sufficient reduction of the portosystemic pressure gradient.
CONCLUSION: In some liver transplant candidates, TIPS can be useful in minimizing the risk of complications of portal hypertension during the waiting time for a liver transplantation. TIPS can be monitored by Doppler US and revised if occlusion occurs.

Entities:  

Mesh:

Year:  2000        PMID: 11016769     DOI: 10.1080/028418500127345712

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  6 in total

1.  Percutaneous transhepatic obliteration for massive variceal rectal bleeding.

Authors:  Munemasa Okada; Yoshiteru Nakashima; Takayuki Kishi; Naofumi Matsunaga; Tsuyoshi Ishikawa; Takao Tamesa; Teppei Yonezawa
Journal:  Emerg Radiol       Date:  2012-02-28

Review 2.  Management of rectal varices in portal hypertension.

Authors:  Kawtar Al Khalloufi; Adeyinka O Laiyemo
Journal:  World J Hepatol       Date:  2015-12-28

3.  Transjugular intrahepatic portosystemic shunts in patients with hepatic malignancy.

Authors:  Michael J Wallace; David C Madoff
Journal:  Semin Intervent Radiol       Date:  2005-12       Impact factor: 1.513

4.  Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis.

Authors:  Zai-Bo Jiang; Hong Shan; Xin-Ying Shen; Ming-Sheng Huang; Zheng-Ran Li; Kang-Shun Zhu; Shou-Hai Guan
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

5.  Preservation of portal pressure improves growth and metabolic profile in the male portacaval-shunted rat.

Authors:  Srinivasan Dasarathy; Kevin D Mullen; Hari S Conjeevaram; Kristine Kaminsky-Russ; Laurie A Wills; Arthur J McCullough
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

6.  Beneficial effect of partial portal decompression using the inferior mesenteric vein for intractable gastroesophageal variceal bleeding in patients with liver cirrhosis.

Authors:  Satoshi Yamamoto; Yoshinobu Sato; Hideki Nakatsuka; Hiroshi Oya; Takashi Kobayashi; Katsuyoshi Hatakeyama
Journal:  World J Surg       Date:  2007-06       Impact factor: 3.282

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.